John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 3,725 shares at $2.15 ($8K) on 2022-07-26, disclosed to the SEC on 2022-07-27.
Scheduled sale ($8k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 2,725 | $6K | 72.5% |
| 2 | $2.22 | 1,000 | $2K | 27.5% |
| Total | $2.17 avg | 3,725 | $8K | 100% |
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |